Dec 2024 | RECOVER Initiative | Journal of Infection
New study results on the incidence of ME/CFS after SARS-CoV-2 infection
After being infected with the SARS-CoV-2 coronavirus, some of the patients develop myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS). This disease is typically characterised by severe fatigue, which impairs day-to-day functioning severely and in some cases leaves the patients in need of care. Viral infections are a known causative agent of ME/CFS.
The RECOVER Initiative has now analysed data of total 11,785 people who were previously infected with SARS-CoV-2, and has published this data in the Journal of General Internal Medicine (JGIM). The analysis has revealed that: Around 5 out of 100 people were still suffering from severe physical and mental fatigue 6 months after the infection and met the diagnostic criteria for ME/CFS. Around 40 out of 100 people had symptoms similar to ME/CFS or fulfilled at least one criterion for ME/CFS. In contrast, approximately 56 out of 100 people reported no symptoms that were typical of ME/CFS. It should be noted that the data is based on self-assessments by those affected and may therefore reflect subjective variations.
Post-exertional malaise (PEM) was reported as the most common ME/CFS symptom. In PEM, symptoms worsen after physical or mental activity. Nearly a quarter of the total people previously infected by SARS-CoV-2 were reported to be affected.
RECOVER Initiative
The RECOVER Initiative was launched by the National Institutes of Health (NIH) in the USA. It is a national research programme designed to better understand, prevent and treat Long COVID.
Journal of Infection
The Journal of Infection is the official journal of the British Infection Association. This Journal publishes original works on various topics surrounding infection. Its target audience includes scientists and physicians.